KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Insulet (PODD) Total Liabilities (2016 - 2026)

Insulet filings provide 16 years of Total Liabilities readings, the most recent being $1.7 billion for Q4 2025.

  • On a quarterly basis, Total Liabilities fell 10.71% to $1.7 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $1.7 billion, a 10.71% decrease, with the full-year FY2025 number at $1.7 billion, down 10.71% from a year prior.
  • Total Liabilities hit $1.7 billion in Q4 2025 for Insulet, up from $1.6 billion in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $2.2 billion in Q1 2025 to a low of $1.3 billion in Q1 2021.
  • Median Total Liabilities over the past 5 years was $1.8 billion (2022), compared with a mean of $1.7 billion.
  • Biggest five-year swings in Total Liabilities: surged 37.73% in 2021 and later dropped 13.75% in 2025.
  • Insulet's Total Liabilities stood at $1.5 billion in 2021, then increased by 18.91% to $1.8 billion in 2022, then rose by 4.55% to $1.9 billion in 2023, then increased by 1.11% to $1.9 billion in 2024, then dropped by 10.71% to $1.7 billion in 2025.
  • The last three reported values for Total Liabilities were $1.7 billion (Q4 2025), $1.6 billion (Q3 2025), and $2.0 billion (Q2 2025) per Business Quant data.